Impact of procedural and patient-related risks on 1-year outcomes for patients with 1-month DAPT followed by P2Y12 inhibitor monotherapy after biodegradable-polymer drug-eluting stent implantation
Event: ESC Congress 2024
Topic: Pharmacotherapy
Session: Data-driven decisions for anticoagulant and antiplatelet therapy
